A patient with a recent myocardial infarction is experiencing acute decompensated heart failure with pulmonary congestion. Which nursing intervention is most appropriate to prioritize in order to improve the patient's respiratory status?

B) Position the patient in high Fowler's position to reduce venous return and improve breathing.

A) Increase the flow rate of supplemental oxygen to improve oxygen saturation.

B) Position the patient in high Fowler's position to reduce venous return and improve breathing.

C) Administer a prescribed dose of morphine sulfate to alleviate anxiety and reduce respiratory distress.

D) Initiate continuous ECG monitoring to detect any arrhythmias.

A patient with a recent myocardial infarction is experiencing acute decompensated heart failure. The nurse notes worsening respiratory distress and pulmonary congestion. Which nursing action should be prioritized to address the pulmonary congestion and improve the patient's respiratory status?

B) Administer furosemide as prescribed to reduce fluid overload

A) Increase the oxygen flow rate to improve saturation

B) Administer furosemide as prescribed to reduce fluid overload

C) Encourage deep breathing exercises to enhance lung expansion

D) Elevate the head of the bed to a 45-degree angle to facilitate breathing

A patient with heart failure is being treated with furosemide and nitroglycerin. Following these interventions, the patient's blood pressure drops to 85/55 mmHg, and serum creatinine increases to 1.6 mg/dL. Which nursing intervention is the most appropriate to address these changes?

C) Administer a fluid bolus to increase blood pressure and improve renal perfusion

A) Increase the rate of nitroglycerin infusion to improve coronary perfusion

B) Titrate down the furosemide dosage to prevent further renal impairment

C) Administer a fluid bolus to increase blood pressure and improve renal perfusion

D) Implement high Fowler's position to enhance respiratory effort and oxygenation

A patient with pulmonary congestion is receiving furosemide and nitroglycerin. After treatment, the patient shows signs of hypotension with a blood pressure of 85/55 mmHg and an increase in serum creatinine to 1.6 mg/dL. Which nursing intervention should the nurse prioritize to address the current concerns?

B) Titrate the nitroglycerin infusion downward and monitor blood pressure

A) Increase the rate of furosemide infusion to enhance diuresis

B) Titrate the nitroglycerin infusion downward and monitor blood pressure

C) Administer additional supplemental oxygen to improve saturation

D) Initiate a fluid bolus to increase blood pressure and renal perfusion

A patient with a recent myocardial infarction is experiencing altered mental status, metabolic acidosis, and hypokalemia. Which nursing intervention is most appropriate to prioritize in this situation?

B) Initiate non-invasive ventilation to support respiratory function

A) Administer supplemental oxygen to improve oxygen saturation

B) Initiate non-invasive ventilation to support respiratory function

C) Administer intravenous potassium to correct hypokalemia

D) Increase the dose of sodium bicarbonate to further correct acidosis

A patient with a recent myocardial infarction is experiencing altered mental status, metabolic acidosis, and hypokalemia. Which intervention should the nurse prioritize to address the patient's immediate needs?

A) Administer supplemental oxygen to improve respiratory effort.

B) Initiate sodium bicarbonate therapy to correct metabolic acidosis.

C) Adjust the furosemide dosage to manage fluid overload.

D) Administer potassium chloride to correct hypokalemia.

A patient with a recent myocardial infarction is experiencing worsening metabolic acidosis, decreased urine output, and elevated serum creatinine levels. Which nursing intervention is most critical to address the potential development of cardiogenic shock in this patient?

C) Prepare for the administration of inotropic agents to enhance cardiac output.

A) Administer additional diuretics to increase urine output.

B) Increase the rate of intravenous fluids to improve renal perfusion.

C) Prepare for the administration of inotropic agents to enhance cardiac output.

D) Implement continuous renal replacement therapy to manage metabolic acidosis.

A patient with a history of myocardial infarction is experiencing worsening metabolic acidosis, decreased urine output, and increased serum creatinine levels. The healthcare team suspects cardiogenic shock. What is the most appropriate nursing intervention to prioritize in this scenario?

C) Prepare for administration of inotropic agents to support cardiac function.

A) Administer supplemental oxygen to improve tissue perfusion.

B) Initiate a fluid bolus to enhance renal perfusion.

C) Prepare for administration of inotropic agents to support cardiac function.

D) Increase diuretic dosage to manage fluid overload.

A patient with cardiogenic shock secondary to left ventricular dysfunction is being treated with low-dose dobutamine to improve cardiac output. Which clinical finding would most likely indicate that the patient's condition is improving?

B) Increase in blood pressure to 100/60 mmHg

A) Decrease in heart rate to 90 beats per minute

B) Increase in blood pressure to 100/60 mmHg

C) Oxygen saturation decreasing to 90%

D) Increased confusion and disorientation

myocardial infarction - Nursing Case Study

Pathophysiology

• Primary mechanism: Myocardial infarction (MI) primarily occurs due to the rupture of an atherosclerotic plaque within the coronary arteries, leading to the formation of a thrombus (blood clot). This clot obstructs blood flow, causing ischemia and necrosis of the heart muscle.

• Secondary mechanism: The ischemic heart tissue triggers an inflammatory response, exacerbating the damage. This involves the infiltration of neutrophils and the release of cytokines, which further impairs myocardial function and promotes tissue remodeling.

• Key complication: If not promptly treated, the loss of viable myocardial tissue can lead to heart failure due to the reduced cardiac output, arrhythmias resulting from electrical instability, and potentially cardiogenic shock, emphasizing the need for immediate intervention.

Patient Profile

Demographics:

62-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Hyperlipidemia

• Current medications: Metoprolol, Lisinopril, Metformin, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe chest pain radiating to the left arm

• Key symptoms: Shortness of breath, nausea, diaphoresis, palpitations

• Vital signs: Blood pressure 160/95 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 98.6°F, oxygen saturation 92% on room air

Section 1

As the medical team initiates treatment for the suspected myocardial infarction, the patient is administered oxygen therapy to improve his oxygen saturation, which has temporarily increased to 95%. Intravenous nitroglycerin is started to help relieve chest pain and reduce cardiac workload, while aspirin and clopidogrel are given to inhibit platelet aggregation and prevent further thrombus formation. Despite these interventions, the patient's condition begins to change; his respiratory distress worsens, indicated by an increase in respiratory rate to 28 breaths per minute, and his oxygen saturation drops to 90% despite supplemental oxygen. Auscultation of the lungs reveals crackles at the bases, suggesting pulmonary congestion.

The clinical team orders an urgent echocardiogram and a repeat set of cardiac biomarkers. The echocardiogram reveals a significant reduction in left ventricular ejection fraction, now estimated at 35%, indicating impaired cardiac contractility. Additionally, there is evidence of left ventricular dilation, which correlates with the crackles heard during the lung assessment. The cardiac biomarkers, specifically troponin I, are markedly elevated, confirming ongoing myocardial injury. These findings suggest the development of acute decompensated heart failure secondary to the myocardial infarction.

This new complication requires a reevaluation of the treatment plan. The heart failure is likely due to the significant myocardial damage and resultant decline in cardiac output. The healthcare team considers the initiation of a diuretic, such as furosemide, to manage the pulmonary congestion and carefully titrates the intravenous nitroglycerin to optimize cardiac function. Close monitoring of the patient's hemodynamic status, renal function, and fluid balance is essential to prevent further deterioration. This situation highlights the importance of addressing the evolving complications of myocardial infarction and necessitates a collaborative, multidisciplinary approach to optimize patient outcomes.

Section 2

As the patient is closely monitored following the initiation of diuretics, his vital signs and clinical status provide significant insights into his response to the interventions. The administration of furosemide begins to alleviate the pulmonary congestion, as evidenced by a gradual decrease in crackles upon auscultation and a slight improvement in his respiratory rate, which drops to 24 breaths per minute. His oxygen saturation shows a modest increase to 92%, still on supplemental oxygen at 4 liters per minute via nasal cannula.

However, the patient's blood pressure begins to show signs of instability, dropping to 85/55 mmHg, raising concerns about potential hypoperfusion and the balance of preload reduction. The healthcare team immediately reassesses the nitroglycerin infusion, deciding to titrate it downward while closely monitoring the patient's hemodynamic status. Additionally, the team evaluates the patient's renal function, noting a slight increase in serum creatinine to 1.6 mg/dL, which warrants careful adjustment of fluid management and diuretic therapy to prevent acute kidney injury.

Despite these challenges, the patient exhibits some improvement in his overall condition. He reports a reduction in chest pain and appears less anxious, which may indicate some stabilization of the myocardial ischemic process. However, the potential for further complications remains, necessitating vigilant monitoring and continued collaboration among the multidisciplinary team. The primary focus now is to stabilize the patient's hemodynamic status and ensure adequate perfusion to vital organs, setting the stage for potential additional therapeutic interventions if required.

Section 3

As the healthcare team continues to monitor the patient, a new complication arises. The patient begins to exhibit signs of altered mental status, becoming increasingly lethargic and difficult to rouse. This change prompts an urgent reassessment, as the team considers the potential causes of his altered neurological state. Vital signs reveal a slight increase in heart rate to 112 beats per minute, while blood pressure stabilizes somewhat at 90/60 mmHg. Oxygen saturation remains at 92%, but the patient's respiratory effort appears more labored.

A review of recent laboratory tests provides further insight. The patient's arterial blood gas analysis shows a pH of 7.31, indicating metabolic acidosis, with a partial pressure of carbon dioxide (PaCO2) at 48 mmHg and bicarbonate (HCO3-) at 18 mEq/L. These findings suggest a mixed respiratory and metabolic component to his acidosis, likely exacerbated by his reduced respiratory drive and potential hypoperfusion contributing to lactic acidosis. Additionally, serum potassium levels have dropped to 3.2 mEq/L, possibly due to diuretic use, further complicating the picture and necessitating careful electrolyte management.

In response to these developments, the healthcare team initiates supplemental sodium bicarbonate therapy to address the metabolic acidosis and adjusts the furosemide dosage while supplementing potassium to prevent further hypokalemia. The team also considers the need for non-invasive ventilation support to improve the patient's respiratory status. This evolving scenario underscores the critical importance of dynamic clinical reasoning to address not only the primary myocardial infarction but also the cascading complications that challenge the patient's recovery path. The focus now shifts to stabilizing the patient's neurological status and optimizing respiratory function, setting the stage for potential further interventions if his condition does not improve.

Section 4

The healthcare team closely monitors the patient's response to the interventions, particularly focusing on his neurological status and respiratory function. Despite the administration of supplemental sodium bicarbonate and potassium, the patient remains lethargic, and his mental status shows minimal improvement. Consequently, the team decides to implement non-invasive ventilation support to assist with his labored breathing. The patient's oxygen saturation improves marginally to 94%, and there is a slight reduction in his respiratory rate, suggesting some initial positive response to the respiratory intervention.

However, a new complication arises as the team notices a decline in urine output, dropping to 20 mL/hour over the past four hours, raising concerns about renal perfusion and potential acute kidney injury. A repeat laboratory evaluation shows worsening metabolic acidosis with a pH now at 7.28, PaCO2 at 50 mmHg, and HCO3- at 16 mEq/L. Furthermore, serum creatinine levels have increased to 2.1 mg/dL from a baseline of 1.0 mg/dL, indicating deteriorating kidney function. This prompts the team to reconsider the patient's fluid status and renal perfusion, exploring possible adjustments in diuretic therapy and fluid management to prevent further renal compromise.

These developments necessitate a reevaluation of the patient's hemodynamic status, as the possibility of cardiogenic shock becomes a growing concern. The team deliberates on escalating pharmacological support with inotropes to improve cardiac output and renal perfusion. The critical balance between managing the myocardial infarction and addressing the secondary complications requires precise clinical reasoning and an adaptive approach to patient care, as the next steps will be crucial in determining the patient's trajectory towards recovery or further deterioration.

Section 5

As the healthcare team continues to monitor the patient, they observe a change in his neurological status. The patient's lethargy has progressed to confusion, and he is now disoriented to time and place. His Glasgow Coma Scale (GCS) score has decreased to 12, highlighting a significant concern regarding cerebral perfusion. The team is worried about the potential impact of ongoing metabolic acidosis and hypoperfusion on his neurological function. Vital signs reveal a heart rate of 110 beats per minute, blood pressure of 85/55 mmHg, and a respiratory rate that has settled to 20 breaths per minute with the assistance of non-invasive ventilation. Oxygen saturation remains at 94%, but there is growing apprehension about his hemodynamic stability.

In response to these alarming changes, the team orders an urgent echocardiogram to assess cardiac function and rule out any significant structural abnormalities that may be contributing to the patient's deteriorating condition. The echocardiogram reveals a reduced ejection fraction of 35%, consistent with left ventricular dysfunction. This finding, combined with the clinical picture, strongly suggests the onset of cardiogenic shock. Arterial blood gas analysis continues to show severe metabolic acidosis with a pH of 7.26, PaCO2 of 52 mmHg, and HCO3- of 15 mEq/L, emphasizing the need for aggressive management to correct the acid-base imbalance and improve perfusion.

Given these developments, the healthcare team deliberates the introduction of inotropic support to enhance cardiac output and stabilize the patient's hemodynamic status. A low-dose infusion of dobutamine is initiated, with careful titration to achieve adequate perfusion without exacerbating the myocardial oxygen demand. As the team implements these measures, they remain vigilant for any signs of improvement or further complications, understanding that the patient's response will be critical in charting the course of his recovery. The ongoing challenge lies in balancing the need for cardiac support with careful monitoring of renal function and metabolic status, necessitating a dynamic and well-coordinated approach to care.